TRIBUNNEWS.COM – Indonesian Dialysis Patient Community (KPCDI) has submitted an application to the Chairman of Commission IX of the House of Representatives of the Republic of Indonesia (DPR RI), Felly Estelita Runtuwene.
This is done to hold a General Hearing Meeting (RDPU) related to the problem of hepatitis C transmission in hemodialysis patients (dialysis).
According to the Chairman of KPCDI, Tony Richard Samosir, the official letter numbered: 05 / KPCDI-PST / IV / 2021, which was sent on April 6, 2021, highlighted the massive number of patients with Chronic Kidney Disease (CKD) in Indonesia who are exposed to the hepatitis C virus.
The exposure occurred when the patients were undergoing the hemodialysis process (dialysis).
Also read: World Kidney Day 2021, KPCDI: Expect a Country for Chronic Kidney Failure Patients in Indonesia
KPCDI research in 2018 with a total respondent of 200 hemodialysis patients showed that 45% of CKD patients were exposed to hepatitis C after they underwent hemodialysis.
If detailed, as many as 43.1% of CKD patients contracted hepatitis C at the age of 1-3 years of the first dialysis process.
“As much as 25.6% in 3-5 years, 12.3% in 5-10 years, 14.3% less than one year, and 4.3% during the hemodialysis process over 10 years,” Tony told Tribunnews, Friday (9/4/2021).
Tony continued, in the case of hemodialysis services, all parties cannot close their eyes if the use of dialysis tubes that are used repeatedly in each hemodialysis operation is the root cause of hepatitis C exposure to patients.
“In relation to hepatitis C virus transmission, dialyser tube reuse can be a risk factor that needs to be considered and considered for its use,” he added.
Tony added that until today there is a gap in rates between different types of hospitals in hemodialysis services. This makes most of the patients in the lower type of hospital do not have the right to medicine.
“For example, the anemia drug erythropoietin. Only type A hospitals routinely provide, while the lower types are difficult for patients to obtain. Finally, the patient chooses a blood transfusion and is at risk of being infected with the hepatitis C virus. And this is very discriminatory, “he said.
Tony urged the government to be able to evaluate the one-package financing system into a separate package between the components of hemodialysis and drugs so that the administration of drugs can be precisely given according to medical indications to patients in need.
“If drugs can be obtained, it will certainly reduce the level of hepatitis C transmission to patients and their families and improve their quality of life,” he concluded.
(Tribunnews.com/Endra Kurniawan)
Other news about the Indonesian Dialysis Patient Community.
–
